Drug archive
Idarubicin (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antineoplastic
Description
Idarubicin (eye-da-RUE-bi-sin) belongs to the general group of medicines known as antineoplastics. It is used to treat some kinds of cancer, including leukemia.
Idarubicin seems to interfere with the growth of cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected by idarubicin, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects, like hair loss, may not be serious but may cause concern. Some effects may not occur for months or years after the medicine is used.
Before you begin treatment with idarubicin, you and your doctor should talk about the good this medicine will do as well as the risks of using it.
Idarubicin is to be administered only by or under the supervision of your doctor. It is available in the following dosage form:
- Injection (U.S. and Canada)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Idamycin
In Canada -
- Idamycin